Stevanato Group has secured €200 million in financing intended to support its ongoing capital expenditure projects in ...

BGENE-DMD is designed to treat Duchenne muscular dystrophy (DMD) via a one-time administration in a single AAV.

Ipsen, a global specialty care biopharmaceutical company, has made the following changes to its Executive Committee: ...

Operational strategies to optimize efficiency and cost effectiveness, and secure an unbroken chain of custody from ...

Sygnature Discovery has completed a major enhancement to its high-throughput chemistry (HTC) capabilities and laboratory infrastructure.

Crown Bioscience’s San Diego laboratory has received Clinical Laboratory Improvement Amendments (CLIA) certification.

Roquette, a provider of plant-based ingredients and pharmaceutical excipients, has launched POLYOX Extended Stability (ES) packaging.

AstraZeneca has announced a $50 billion investment in the United States by 2030, creating tens of thousands of new, highly ...

Jeff Sheehan, Managing Partner at Trinity Capital, Spark’s developer, commented, “Coriolis Pharma’s decision to establish ...

Solvias' Center of Excellence for biologics and novel modalities in Research Triangle Park, North Carolina, is now cGMP ready ...

Vicebio Ltd, a biopharmaceutical company developing novel vaccines, has entered an exclusive, definitive agreement to be ...

Abzena, an end-to-end integrated CDMO and CRO, has appointed Geoffrey M. Glass as Chief Executive Officer (CEO), effective ...